Evidence map›Paper›PMID 41424163›Full record

ReviewTherapeutic advances in respiratory disease

Primary pulmonary chondrosarcoma: clinical case and review of the literature.

Christopher Milacek, Yasmin Merza, Felicitas Oberndorfer, Konrad Hoetzenecker, Daniela Gompelmann, Marco Idzko, Anastasia Papaporfyriou

Abstract readCase ReportsReview
In one paragraph

Review in Therapeutic advances in respiratory disease. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Christopher MilacekDivision of Pulmonology, Department of Internal Medicine II, Medical University of Vienna, Vienna, Austria.
Yasmin MerzaDivision of Pulmonology, Department of Internal Medicine II, Medical University of Vienna, Vienna, Austria.
Felicitas OberndorferDepartment of Pathology, Medical University of Vienna, Vienna, Austria.
Konrad HoetzeneckerDepartment of Thoracic Surgery, Medical University of Vienna, Vienna, Austria.
Daniela GompelmannDivision of Pulmonology, Department of Internal Medicine II, Medical University of Vienna, Vienna, Austria.
Marco IdzkoDivision of Pulmonology, Department of Internal Medicine II, Medical University of Vienna, Vienna, Austria.
Anastasia PapaporfyriouDivision of Pulmonology, Department of Internal Medicine II, Medical University of Vienna, Waehringer Guertel 18-20, Vienna 1090, Austria.ORCID 0000-0002-5479-4649

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Mesenchymal chondrosarcoma is a malignant tumor that arises from cartilage-forming cells and typically affects the bones, but in rare cases also the lungs. Due to its rarity, there is limited knowledge about the clinical presentation, diagnostic challenges, and treatment options for primary pulmonary chondrosarcoma. We conducted a comprehensive literature search through PubMed, EMBASE, Scopus, Clinical Trial Gov, and Google Scholar using search terms such as "primary pulmonary/lung chondrosarcoma." We also present our case study. In our case, the chondrosarcoma was discovered incidentally during a Computer Tomography (CT) scan. It was located in the middle lobe and was historically characterized as low-grade. After surgical removal, no recurrence was detected during follow-up examination. In the literature reviewed, the most common symptoms of primary pulmonary chondrosarcoma were cough and dyspnea. Radiologic features included well-defined margins, a central location, and calcifications. Histopathological examination revealed either hyaline or myxoid structures, with the myxoid type being more aggressive. Surgical resection is currently the preferred treatment method with a recurrence rate of approximately 21%.Primary pulmonary mesenchymal chondrosarcoma remains a rare and challenging diagnosis, typically presenting with non-specific symptoms. Surgical resection is the primary treatment method. Further research is needed to establish standardized diagnostic criteria and treatment protocols.

Indexed as

Chondrosarcoma, MesenchymalLung NeoplasmsChondrosarcomaHumansIncidental FindingsPneumonectomyTomography, X-Ray ComputedTreatment Outcomecartilage tumorcase reportpulmonary chondrosarcomarare lung tumor

Identifiers

PMID41424163
PMCPMC12722692

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.